occurr
felin
leishmaniosi
fel
increas
worldwid
reveal
possibl
role
cat
leishmaniosi
epidemiolog
better
accuraci
laboratori
techniqu
improv
diagnosi
diseas
chang
ecosystem
last
year
associ
use
repel
dog
might
play
role
sandfli
alter
feed
pattern
urban
area
lead
infect
mammalian
worldwid
epidemiolog
survey
leishmania
speci
caus
felin
asymptomat
infect
fel
europ
spain
first
describ
fel
case
author
claim
low
preval
fel
endem
area
may
relat
natur
resist
parasit
moreov
number
clinic
case
may
underestim
lead
report
lack
inform
clinician
owner
although
portug
endem
countri
canin
leishmaniosi
caus
leishmania
infantum
publish
clinic
report
fel
first
descript
sesimbra
follow
other
porto
despit
occasion
report
ocular
viscer
diseas
dermatolog
mucocutaneousmucos
present
lymph
node
enlarg
frequent
clinic
clinic
suspicion
base
histori
clinic
sign
clinicopatholog
abnorm
diagnosi
confirm
parasitolog
serolog
longterm
administr
allopurinol
mgkg
recommend
treatment
protocol
howev
similarli
dog
recurr
occur
infect
clear
author
report
good
clinic
respons
use
nmethylglucamin
antimoni
monotherapi
mgkg
mgcat
sc
im
differ
protocol
studi
aim
describ
treatment
recur
clinic
case
fel
cat
receiv
combin
therapi
allopurinol
nmethylglucamin
antimoni
domest
european
neuter
male
cat
refer
veterinari
teach
hospit
faculti
veterinari
medicin
univers
lisbon
multipl
nodular
skin
lesion
figur
ulcer
dermat
involv
four
limb
figur
fever
cat
refer
year
onset
skin
lesion
previous
treat
presumpt
pyodermat
prednisolon
mgkg
po
day
amoxicillinclavulan
acid
mgkg
po
day
follow
doxycyclin
mgkg
po
day
show
clinic
improv
cat
vaccin
regularli
protect
ectoparasit
fipronil
imidacloprid
first
admiss
mild
fever
dermatolog
lesion
head
limb
abnorm
physic
examin
skin
nodul
measur
mm
diamet
distribut
outer
pinnal
surfac
figur
orbit
region
figur
observ
pinna
gather
coalesc
pattern
differenti
diagnosi
pyodermat
allerg
reaction
autoimmun
diseas
neoplast
diseas
leishmaniosi
singl
spot
mm
diamet
ulcer
dermat
rais
margin
affect
antebrachi
figur
hock
figur
region
complet
blood
count
biochem
profil
use
evalu
clinic
statu
cat
treatment
treatment
followup
examin
urinalysi
urinari
protein
creatinin
ratio
evalu
month
treatment
haematolog
biochem
valu
within
refer
interv
serum
protein
electrophoresi
show
albumin
globulin
ratio
slight
hypergammaglobulinaemia
evid
tabl
patient
test
fivspecif
antibodi
felv
antigen
elisa
virachekfiv
virachekfelv
respect
synbiot
immunoflouresc
antibodi
test
ifat
use
adapt
leishmania
spot
ifi
kit
fluoresc
label
anticat
igg
conjug
anticat
igg
megacor
megacor
diagnostik
use
quantifi
antileishmania
antibodi
cutoff
previou
studi
includ
cat
valid
latter
test
interlaboratori
assay
use
known
posit
neg
sera
result
expect
repeat
reproduc
also
assess
unpublish
result
cat
test
neg
fiv
antibodi
felv
antigen
posit
antileishmania
antibodi
titr
tabl
fineneedl
aspir
punctur
ear
skin
nodul
perform
smear
stain
giemsa
merck
examin
optic
microscop
olympu
aspir
also
use
molecular
parasitolog
analysi
smear
reveal
leishmania
amastigot
figur
absenc
bacterianeutrophil
infiltr
characterist
cell
autoimmun
diseas
dna
extract
edta
blood
sampl
skin
nodul
lymph
node
aspir
carri
dneasi
blood
tissu
kit
qiagen
detect
felin
coronaviru
plasma
perform
revers
transcript
quantit
pcr
rtqpcr
target
end
viru
genom
addit
qpcr
use
l
infantumspecif
taqman
probe
target
kinetoplast
minicircl
dna
kdna
also
perform
determin
initi
followup
parasit
rtqpcr
neg
coronaviru
qpcr
skin
nodul
blood
sampl
posit
l
infantum
kdna
show
parasit
load
parasit
per
ng
dna
respect
tabl
nodular
lymph
node
aspir
inocul
schneider
insect
medium
sigmaaldrich
supplement
wv
mm
hepe
fetal
bovin
serum
uml
penicillin
cultur
maintain
refriger
incub
lovibond
observ
optic
microscopi
day
incub
viabl
promastigot
observ
cat
treat
oral
mgkg
allopurinol
threelay
bandag
appli
four
limb
medic
followup
perform
everi
day
first
fortnight
day
treatment
allopurinol
slight
clinic
improv
note
fever
persist
skin
ulcer
seem
equal
profound
therefor
combin
therapeut
protocol
yet
approv
cat
suggest
owner
nmethylglucamin
antimoni
administr
offlabel
cat
publish
case
fel
treat
drug
owner
consent
obtain
treatment
reinforc
mgkg
nmethylglucamin
antimoni
glucantim
merial
sc
consecut
day
studi
conduct
framework
fct
project
agreement
ethic
committe
anim
welfar
faculti
veterinari
medicin
univers
lisbon
treatment
abnorm
report
owner
cat
maintain
normal
physic
examin
apart
skin
lesion
total
remiss
skin
nodul
head
well
foreleg
ulcer
achiev
figur
bodi
temperatur
normalis
day
complet
closur
hindlimb
ulcer
lesion
occur
owe
extrem
tension
region
requir
surgeri
figur
one
hour
prior
surgeri
cat
receiv
therapeut
protocol
ringer
lactat
fluid
therapi
amoxicillin
clavulan
acid
mgkg
im
buprenorphin
mgkg
im
methylprednisolon
succin
mgkg
im
propofol
mgkg
iv
use
induct
anaesthesia
follow
isofluran
mainten
debrid
excis
wound
edg
perform
horizont
mattress
sutur
use
closur
excis
edg
defect
immers
formalin
solut
allow
histopatholog
studi
cat
medic
antibiot
amoxicillinclavulan
acid
mgkg
po
day
nonsteroid
antiinflammatori
tolfenam
acid
mgkg
po
q
day
assess
h
surgeri
order
evalu
region
oper
stitch
remov
day
integr
part
heal
process
cat
maintain
week
robertjon
bandag
complet
heal
hindlimb
lesion
achiev
month
surgeri
figur
histolog
examin
remov
tissu
show
granulomatouslik
inflammatori
respons
foci
lymphocyt
activ
plasmacyt
occasion
intracellular
amastigot
form
leishmania
speci
macrophag
slight
hypergammaglobulinaemia
observ
admiss
return
normal
valu
clinic
laboratori
chang
detect
month
end
treatment
tabl
allopurinol
stop
antibodi
titr
decreas
month
month
antibodi
level
remain
unchang
parasit
load
decreas
blood
skin
nodul
day
combin
treatment
lymph
node
parasit
load
show
pronounc
decreas
day
tabl
fel
rare
report
variou
part
europ
total
clinic
case
publish
name
itali
franc
spain
switzerland
regard
cat
import
portug
although
first
clinic
case
report
recent
year
epidemiolog
studi
conduct
better
understand
role
cat
biolog
cycl
leishmania
speci
metropolitan
region
lisbon
although
detect
antileishmania
antibodi
titr
point
low
preval
least
low
contact
detect
leishmania
dna
indic
high
level
infect
stray
domest
cat
even
anim
diseas
seldom
consid
differenti
diagnosi
cat
present
clinic
case
anim
previous
treat
diseas
year
dermatolog
find
fel
usual
includ
erythema
alopecia
papul
nodul
ulcer
crust
head
affect
region
bodi
part
may
also
present
clinic
case
ulcer
hindlimb
sever
contamin
first
examin
possibl
determin
whether
fever
system
sign
fel
consequ
secondari
bacteri
infect
concern
avail
therapeut
fel
cat
first
treat
allopurinol
insuffici
despit
use
common
treatment
canin
leishmaniosi
even
though
use
allopurinol
offlabel
dog
cat
extens
clinic
experi
efficaci
safeti
dog
scope
cascad
combin
therapeut
yet
approv
cat
suggest
owner
initi
cat
show
high
antibodi
titr
ifat
seen
report
case
week
combin
protocol
decreas
antibodi
titr
parasit
load
evid
similarli
canin
leishmaniosi
gradual
declin
antibodi
titr
took
around
month
attain
lowest
titr
clinic
remiss
accomplish
togeth
surgic
recoveri
less
month
furthermor
therapeut
protocol
seem
safe
cat
analyt
chang
side
effect
observ
month
followup
relaps
occur
regard
albumin
level
although
within
refer
interv
increas
note
associ
decreas
gamma
globulin
valu
kept
total
protein
concentr
within
refer
interv
agreement
remiss
clinic
sign
cat
may
live
year
slowli
progress
chronic
diseas
even
without
specif
antileishmania
howev
case
sever
cutan
lesion
clinician
main
concern
lead
search
anoth
therapeut
protocol
monotherapi
allopurinol
prove
insuffici
although
full
clinic
recoveri
achiev
possibl
much
reduc
number
viabl
parasit
may
persist
mainli
lymph
node
end
treatment
howev
possibl
guarante
total
elimin
dispers
skin
parasit
transmiss
kept
mind
fact
highlight
need
new
topic
insecticid
aim
prevent
sandfli
bite
cat
insecticid
product
current
regist
sandfli
contain
permethrin
extrem
toxic
cat
present
work
describ
success
case
fel
treatment
young
cat
neg
fiv
antibodi
felv
antigenaemia
day
refractori
period
use
allopurinol
monotherapi
best
knowledg
first
report
combin
therapi
use
allopurinol
nmethylglucamin
antimoni
relaps
advers
effect
result
possibl
new
treatment
use
fel
refractori
case
